Cardiac simulator
DeviceA computer software cardiac simulator for surgical planning in complex Congenital Heart Disease (CHD) pediatric patients.
NCT Number: NCT06373705
The goal of this clinical trial is to learn if a computer software program (cardiac simulator) for surgical planning will lead to improvements in patient care by decreasing the incidence of unsuccessful interventions and reinterventions for pediatric patients with congenital heart disease. It is not a commercially available device to treat congenital heart disease in pediatric patients. The main aims are:
To provide safe pre-operative testing of surgical approaches with a computer model cardiac simulator.
To aid surgeons in envisioning different surgical approaches for each individual patient.
To bolster the standard of care surgical planning discussions which will be particularly useful for patients with unique, complex congenital heart disease.
Participants will:
Consent to being randomized with a 50% chance of receiving standard of care "on the fly" surgical planning discussion as is current practice or assisted surgical planning discussion with the aid of the computer software cardiac simulator.
Receive results of their computer simulated findings during their surgical planning discussion if they are in the cardiac simulator group.
Trial opening soon.
Get NotifiedUp to 17 year
All sexes
Interventional
Not applicable
The computer software will be developed at the Cardiovascular Biomechanics Computation Lab at Stanford.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A computer software cardiac simulator for surgical planning in complex Congenital Heart Disease (CHD) pediatric patients.
Time frame: At date of hospital discharge or up to 30 days post-operation
Alive or deceased post-operative
Time frame: Latest follow-up exam up to 3 years post-operation
Alive or deceased long-term
Time frame: Up to 10 hours
Due to quality of pathways to blood flow, function of inlet and outlet valves, or residual hemodynamic lesions during operation (up to 5 times)
Time frame: At date of hospital discharge or up to 30 days post-operation
Due to quality of pathways to blood flow, function of inlet and outlet valves, residual hemodynamic lesions
Time frame: Up to approximately 10 hours intra-operation
Hours and minutes of operative duration
Time frame: Immediately post-operation, at date of discharge, follow-up to 3 years
Echocardiogram
Time frame: At 1 year post-operation
MRI
Time frame: At 1 year post-operation
Catheterization
Time frame: Immediately post-operation, at date of discharge, follow-up to 3 years
Echocardiogram
Time frame: At 1 year post-operation
MRI
Time frame: Valvular function
Catheterization
Time frame: At discharge date up to 180 days
Length of time from date of operation to discharge from hospital
Time frame: At discharge date up to approximately 3 weeks
What inotropes were administered post-operation
Stanford University
Other
Utilizing a Multi-Physics Cardiac Simulator for Surgical Planning in Complex Congenital Heart Disease Pediatric Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728136
Acute Respiratory Distress Syndrome, Congenital Heart Disease in Children
View Trial DetailsNCT07574463
Cardiovascular Abnormalities, Cardiovascular Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT04158024
Congenital Heart Disease in Children, Neurologic Complication
View Trial DetailsNCT06912412
Cardiovascular Abnormalities, Cardiovascular Diseases
Seoul, South Korea
View Trial Details